Quinolone resistance in Helicobacter pylori isolates in Germany.
about
Prevalence of Primary Antimicrobial Resistance of H. pylori in Turkey: A Systematic Review.Antimicrobial resistance of H. pylori to the outcome of 10-days vs. 7-days Moxifloxacin based therapy for the eradication: a randomized controlled trial.Second-line rescue therapy of helicobacter pylori infection.Surveillance of Helicobacter pylori Antibiotic Susceptibility in Indonesia: Different Resistance Types among Regions and with Novel Genetic Mutations.Primary antibiotic resistance and associated mechanisms in Helicobacter pylori isolates from Senegalese patients.The incidence of primary antibiotic resistance of Helicobacter pylori in VietnamThe Association of Age and Antibiotic Resistance of Helicobacter Pylori: A Study in Jiaxing City, Zhejiang Province, China.Molecular Detection of Antibiotic Resistance in South African Isolates of Helicobacter pyloriControlling mutation: intervening in evolution as a therapeutic strategy.Antibiotics resistance rate of Helicobacter pylori in BhutanIsolation of Helicobacter pylori in gastric mucosa and susceptibility to five antimicrobial drugs in Southern chile"Rescue" regimens after Helicobacter pylori treatment failure.Evaluation of a new test, genotype HelicoDR, for molecular detection of antibiotic resistance in Helicobacter pylori.An African perspective on Helicobacter pylori: prevalence of human infection, drug resistance, and alternative approaches to treatment.Sequential therapy or triple therapy for Helicobacter pylori infection: systematic review and meta-analysis of randomized controlled trials in adults and children.Effect of fluoroquinolone resistance on 14-day levofloxacin triple and triple plus bismuth quadruple therapy.Helicobacter pylori resistance rates for levofloxacin, tetracycline and rifabutin among Irish isolates at a reference centre.The efficacy of moxifloxacin-based triple therapy in treatment of Helicobacter pylori infection: a systematic review and meta-analysis of randomized clinical trials.Antimicrobial susceptibility testing for Helicobacter pylori in times of increasing antibiotic resistance.Systematic review with meta-analysis: the efficacy of levofloxacin triple therapy as the first- or second-line treatments of Helicobacter pylori infection.Primary Antimicrobial Susceptibility Changes in Children with Helicobacter pylori Infection over 13 Years in Northern Italy.Antimicrobial resistance of Helicobacter pylori strains to five antibiotics, including levofloxacin, in Northwestern Turkey.Should quinolones come first in Helicobacter pylori therapy?Rescue Therapy for Helicobacter pylori Infection 2012.Resistance to amoxicillin, clarithromycin and ciprofloxacin of Helicobacter pylori isolated from Southern Brazil patients.Geographic map and evolution of primary Helicobacter pylori resistance to antibacterial agents.Identification and molecular characterization of triple- and quadruple-resistant Helicobacter pylori clinical isolates in Germany.High secondary resistance to quinolones in German Helicobacter pylori clinical isolates.Effectiveness and safety of repeated quadruple therapy in Helicobacter pylori infection after failure of second-line quadruple therapy: repeated quadruple therapy as a third-line therapy.Microarray-Based Detection and Clinical Evaluation for Resistance to Clarithromycin or Levofloxacin and the Genotype of CYP2C19 in 1083 Patients
P2860
Q30252088-6F057925-D46F-46BF-92D6-05E3934084DAQ33843119-D68F5D83-313D-45D1-9AFA-057B9B886E5FQ34409114-3AAB8018-F934-4FC6-8BBD-74D81229B589Q36209645-AE93EC66-FF1D-4025-AD52-A6AA7BED7B4FQ36556466-4950C342-D1C5-4D5A-9D00-9B0E38E08DA9Q36565896-97BB36D3-3F18-4393-9B3E-6E93AF346278Q36653595-50FD6318-5444-4F76-904B-8623D1926778Q36848571-C8285C22-86EB-4407-9114-900244F61C3AQ36961674-E821CCA4-6696-4D5A-B991-62A88FBF1AF4Q37142225-40F4ED2D-5BC6-4725-A901-DE1AB4373B47Q37162292-15414918-7291-4E09-8AB4-D1B9D82633E4Q37273653-3D06BA81-526C-479D-8EB3-5D6AE7D1C3C9Q37410463-85F33B52-9A7D-40C3-816A-5DD708FFC64CQ37430439-43C147D7-D0BB-433D-8485-D1F174E73FC9Q37618534-ADC520FE-C0BE-46A9-8334-4AFDB26354F3Q37682593-A02B8986-D733-4242-AFF1-EC18BA999BCBQ38102589-66537D9A-9952-4A38-AB80-A785DC765F8AQ38125597-2B2D73EB-BE37-4BE3-9FC8-9DA068638B8AQ38238746-749FA225-322C-446B-8C85-AF2347198246Q38882190-7B9E79D3-9932-481C-9507-0EF8AA6C82C6Q40865462-A0A12DF9-BDE0-4EEC-9B9F-814512DA9DCEQ41141990-F5FFA192-D635-4633-98E2-9B8AD06685EDQ41807465-B6C66794-D098-46B1-9FB2-28653C4213B2Q42129420-220792AA-C5D3-4176-8D92-1CCD7C95F0F4Q42724145-2B79E2F7-5D74-4F34-91DC-28B674778B54Q43218781-FE30F012-6B85-4C26-A67F-96B1216F782FQ44790817-1FF44B7D-42C7-4B49-972B-89B1F1CC66C5Q46197929-D929532B-08A1-45A6-BB39-A00BBE7D8838Q51008107-95DB64EF-B510-49D0-80F3-66E1D0178CD6Q57114157-EC8559ED-A61D-4D23-8E63-841FCCCFB735
P2860
Quinolone resistance in Helicobacter pylori isolates in Germany.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Quinolone resistance in Helicobacter pylori isolates in Germany.
@en
Quinolone resistance in Helicobacter pylori isolates in Germany.
@nl
type
label
Quinolone resistance in Helicobacter pylori isolates in Germany.
@en
Quinolone resistance in Helicobacter pylori isolates in Germany.
@nl
prefLabel
Quinolone resistance in Helicobacter pylori isolates in Germany.
@en
Quinolone resistance in Helicobacter pylori isolates in Germany.
@nl
P2093
P2860
P921
P356
P1476
Quinolone resistance in Helicobacter pylori isolates in Germany.
@en
P2093
Erik Glocker
Hans-Peter Stueger
Manfred Kist
P2860
P304
P356
10.1128/AAC.00614-06
P407
P577
2006-10-16T00:00:00Z